🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Stay up to date with the latest on Therapeutic Research and Development published in Cancer Research Communications. brnw.ch/21wTiBR

Recently published: #GeneticAncestry, Intrinsic Tumor Subtypes, and #BreastCancerSurvival in Latin American Women, by Daniela Alves da Quinta et al. doi.org/10.1158/2767-9… Andrea Llera Javier Retamales Ricardo Verdugo UCDavisMedSchool UC Davis Comprehensive Cancer Cent #HER2 #BreastCancer #OpenAccess

Recently published: Protein-level Analysis of Differential Response to Chemotherapy in #TNBC Identifies #CYP1B1 as a Biomarker for #ChemotherapyResistance, by F. Scott Heinemann and Paul D. Gershon. doi.org/10.1158/2767-9… Hoag UCI Charlie Dunlop School of Biological Sciences #OpenAccess

Recently published: #HDAC Inhibitors Target #DNAReplication Regulators and #ReplicationStress in #EwingSarcoma Cells, by Stacia L. Koppenhafer et al. doi.org/10.1158/2767-9… UI Health Care Stead Family Children's Hospital UIowaNeuroPharm Internal Medicine at Iowa #HDACi #OpenAccess

Stay up to date with the latest research on Precision Medicine and Biomarkers published in Cancer Research Communications. brnw.ch/21wTlOp

Recently published: Defining #NSCLC #TumorMicroenvironment Changes at Primary and Acquired #ImmuneCheckpointInhibitor Resistance Using Clinical and Real-world Data, by Lang Ho Lee et al. doi.org/10.1158/2767-9… Joel Wagner Novartis Science #OpenAccess

Sign up to receive alerts directly to your inbox to keep up with the latest published issues: aacrjournals.org/pages/alerts

Stay up to date with the latest on Clinical Research and Trials published in Cancer Research Communications. brnw.ch/21wTr2L

Stay up to date with the latest research on Molecular and Cellular Biology published in Cancer Research Communications. brnw.ch/21wTv93

Just published: An #Acrolein-Based Drug Delivery System Enables Tumor-Specific Sphingosine-1-Phosphate Targeting in #BreastCancer without #Lymphocytopenia, by Masayuki Nagahashi et al. doi.org/10.1158/2767-9… Science Tokyo （東京科学大学） RIKEN 大阪国際大学 #S1P #OpenAccess

Stay up to date with the latest research on Emerging Technologies and Data Science published in Cancer Research Communications. brnw.ch/21wTyJ6

Recently published: Racial Disparities in Analgesic and Psychiatric Medication Use during End-of-Life Care in Advanced-Stage #ColorectalCancer: A Retrospective Cohort Study, by John M. Allen et al. doi.org/10.1158/2767-9… 𝗝𝗼𝗵𝗻 𝗔𝗹𝗹𝗲𝗻 David DeRemer #HealthEquity #OpenAccess

Stay up to date with the latest research on Immuno-oncology published in Cancer Research Communications. brnw.ch/21wTEbh

Recently published: Uncovering Novel #lncRNAs Linked to #Melanoma Growth and Migration with #CRISPR-Inhibition Screening, by Stavroula Petroulia et al. doi.org/10.1158/2767-9… Eric Wang Aristotelis Tsirigos MPI Dortmund NYU Grossman School of Medicine #CRISPRi #OpenAccess

Recently published: A Phase 1b/2 Study of TP-0903 and #Decitabine Targeting Mutant #TP53 and/or Complex Karyotype in Patients with Untreated #AcuteMyeloidLeukemia (AML) ≥ Age 60 years doi.org/10.1158/2767-9… Joshua Zeidner MD Yazan Madanat, MD Ashley Yocum #OpenAccess

Recently published: Phase I First-in-Human Study of TRK-950, an #IgG1 Antibody Specific to CAPRIN-1, in Patients with #AdvancedSolidTumors, by Philippe A. Cassier et al. doi.org/10.1158/2767-9… Jean-Yves Blay Centre Leon Berard CRCL #OpenAccess

Recently published: #Adiposity Status Close to Diagnosis and Its association with #ProstateCancerSurvival in the #UKBiobank, by Margarita Cariolou et al. doi.org/10.1158/2767-9… Kostas Tsilidis Margarita Cariolou Imperial School of Public Health #ProstateCancer #OpenAccess

Recently published: Assessing Racial Disparities in Guideline-Concordant Care and Clinical Outcomes after Surgical Resection of Non-Metastatic #ColonCancer at a Comprehensive Cancer Center, by Christina I. Lee et al. doi.org/10.1158/2767-9… @sharaf501 Memorial Sloan Kettering Cancer Center #OpenAccess

Just published: The #XPO1 Inhibitor Eltanexor Modulates the Wnt/β-Catenin Signaling Pathway to Reduce #ColorectalCancer Tumorigenesis, by Andrew E. Evans et al. doi.org/10.1158/2767-9… Anup Kasi MD MPH KU Medical Center KU Cancer Center UAMS Cancer #Chemoprevention #OpenAccess

Stay up to date with the latest on Health Disparities and Outcomes Research published in Cancer Research Communications. brnw.ch/21wTXty